Videodensitometric vs edge-detection quantitative angiography. Insights from intravascular ultrasound imaging
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Intravascular ultrasound has the unique ability to provide direct visualization of the atherosclerotic plaque on the coronary vessel wall in vivo [1] [2] [3] . The echoreflectivity of the plaque may be used as a surrogate to determine its underlying histology [1] [2] [3] . Intravascular ultrasound is a tomographic technique unsurpassed in providing accurate measurements of both lumen area and total vessel area [1] [2] [3] . This comprehensive information has represented a major breakthrough in our understanding of coronary artery disease, a disease of the vessel wall. In most patients, however, clinical manifestations only arise when the plaque burden is large enough to impinge on and narrow the coronary lumen to some extent. Discrete lumen stenoses are well detected by angiography, a technique suited to depicting the coronary lumen silhouette as a shadowgram image [1] [2] [3] . Likewise, comparing the minimal lumen diameter of the target lesion with the adjacent angiographically normal reference segment provides a precise measurement of relative lumen narrowing. This in turn is classically considered a valid estimation of stenosis severity. In the last decade, however, the paradigm for considering coronary angiography as the 'gold standard' for the diagnosis of coronary artery disease has been critically challenged [1] [2] [3] . Nowadays, the cardiological community is well aware of the limitations of conventional angiography. This has affected not only its acceptance as a reliable research tool, but also its so far undisputed utility for clinical decision making.
Intravascular ultrasound studies have confirmed previous anatomopathological observations, suggesting that angiography underestimates the extent and severity of coronary artery disease [1] [2] [3] . The angiographically normal reference segment is universally involved in the atheromatous process, explaining why discrete lesion severity may be underestimated [1] [2] [3] . Furthermore, the pathophysiological mechanism, causing coronary narrowing, is largely undetected by angiography. On the one hand, the underlying substrate (plaque rupture and associated thrombus) is overlooked in most patients with acute coronary syndromes [4] . On the other, we have learned that the arterial wall is able to experience 'remodelling', which further confuses our interpretation of serial angiographic lumen changes [3] . Although many lesions occur in the setting of positive remodelling (which eventually fails to compensate for plaque growth), others are produced by negative remodelling, implying that vessel shrinkage (and not plaque accumulation) accounts for most of the lumen narrowing [3] . Last but not least, visual assessment of coronary angiograms is associated with large inter-and intraobserver variability.
In this context, quantitative coronary angiography has proved to be a valuable technique in providing reliable and reproducible measurements, alleviating the subjectivity and variability of visual assessment [5] [6] [7] [8] [9] [10] . Experimental studies have validated the performance (accuracy and precision) of quantitative coronary angiography derived measurements against true values obtained from phantom stenoses [9] . In the clinical setting, however, vessel foreshortening and overlapping side-branches remain practical limitations [5] [6] [7] [8] [9] [10] . In addition, despite the use of multiple views, angiography may misrepresent the extent of luminal narrowing in eccentric lesions [5, 6] . Furthermore, debate still exists regarding the relative merits of the two quantitative coronary angiography techniques more frequently used, namely edgedetection and videodensitometry [6] [7] [8] [9] [10] . In edgedetection quantitative coronary angiography the boundaries of the selected coronary segment are automatically detected by an algorithm using the weighted sum of the first and second derivative functions of the brightness profile. The reference segment is either selected by the operator or automatically interpolated by the system. The catheter, used as a scaling device, allows absolute measurements. Eventually, lumen cross-sectional areas are 'calculated' from orthogonal projections (assuming an elliptic model) or from the worst view (as a circle) [6] [7] [8] [9] [10] . Conversely, videodensitometry is based on the relationship between the optical density of the contrast filled lumen and absolute vessel dimensions. The cross-sectional area function is obtained from brightness values calibrated for the amount of X-ray absorption after subtracting the background contribution. Calibration of videodensitometric images are performed by equalizing the reference area to that calculated from the edge-detection algorithm [6] [7] [8] [9] [10] . Therefore, this technique measures vessel dimensions independent of lesion contour and luminal shape. It requires, however, homogeneous complete opacification of the lumen and may be less reliable in calcified vessels. Whereas edge-detection quantitative coronary angiography has gained widespread acceptance, the clinical value of videodensitometry remains controversial.
Theoretically speaking, direct measurements from tomographic intravascular ultrasound images will provide the method of choice to accurately determine the coronary lumen area [1] [2] [3] . Recent studies have demonstrated the clinical applications of lumen dimensions assessed by intravascular ultrasound. In these studies, the intravascular ultrasound-derived minimal luminal area kept a better correlation with the physiological significance of coronary lesions (using the pressure-derived fractional flow reserve as the reference) than quantitative coronary angiography analysis [11] [12] . Although intravascular ultrasound currently provides the most precise tool for measuring the vessel lumen area, this technique also has some specific problems and inherent limitations [1] [2] [3] 13] as summarized in Table 1 . In many of these circumstances intravascular ultrasound tends to overestimate the lumen area.
Reported in this issue is an elegant and thorough study from Peters et al. [14] , that gives us more insight into the meaning of lumen quantification with different quantitative coronary angiography techniques. They evaluated the correlations between edge-detection quantitative coronary angiography, videodensitometry and intravascular ultrasound in 161 patients after successful balloon angioplasty. These patients were selected from a larger study (PICTURE) designed to determine predictors of restenosis [15] . Intravascular ultrasound-derived lumen dimensions corresponded more closely to videodensitometry than to edge-detection quantitative coronary angiography measurements. However, minimal lumen area, as obtained by intravascular ultrasound (manual pullback), was significantly larger than that measured by videodensitometry (difference of means 1·65 mm 2 ), which, in turn, was significantly larger than that obtained by edge-detection quantitative coronary angiography (difference of means 0·85 mm 2 ). These relatively large differences may appear difficult to explain but confirm data from previous studies [6] [7] [8] [9] [10] . In addition, the correlation between the three techniques was not influenced by the presence of dissections (either by intravascular ultrasound or angiography) but the correlation between videodensitometry and intravascular ultrasound significantly improved in non-calcified lesions.
The study of Peters et al. [14] should be put into perspective with previous reports assessing lumen size correlation among quantitative techniques. As several factors (Table 1) explain why intravascular ultrasound is not universally accepted as the gold standard for lumen dimension measurements, in the absence of known true values, the Bland and Altman method (mean and SD of the between-method difference) is required as an index of agreement between techniques. Most initial studies found a relatively good correlation between angiography and intravascular ultrasound in normal looking segments and in simple lesions, whereas the correlation 
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deteriorated in complex lesions or following intervention [3] [4] [5] [6] . In a detailed study, Ozaki et al. [10] suggested that lesions with complex morphology and those studied after interventions (haziness, dissections), account to a great extent for the discrepancies between the two quantitative coronary angiography techniques. It was concluded that the agreement between intravascular ultrasound and quantitative coronary angiography progressively deteriorated according to the degree of vessel damage, but this finding was less evident with videodensitometry [10] . In fact, the correlation coefficient between videodensitometry and intravascular ultrasound increased after intervention. Of interest, despite using a similar quantitative coronary angiography system, the correlation between intravascular ultrasound and videodensitometry was much better than that found by Peters et al. [14] . These observations concurred with previous data from von Birgelen et al. [7] showing that agreement between edgedetection quantitative coronary angiography and videodensitometry was good after rotational atherectomy because the intervention yielded smooth and symmetrical lumens. However, dispersion increased after adjunctive balloon angioplasty which generated more irregular lumens [7] . Finally, after stent deployment, and despite the device's metallic struts, a particularly good agreement was found between intravascular ultrasound and videodensitometry, whereas correlation between intravascular ultrasound and edge-detection quantitative coronary angiography remained slightly behind, probably due to some asymmetrical stent configurations [8] . Ultimately, the concept that intravascular ultrasound and videodensitometry are projection independent appears to be a key factor to explain such findings [6] [7] [8] [9] [10] . The work of Peters et al. [14] gives important information on the differences obtained when currently available approaches of lumen quantification are compared. Videodenstometric lumen dimensions match more closely intravascular ultrasound-derived dimensions than do those obtained by edge-detection quantitative coronary angiography. However, this work also casts new shadows on potential niche indications of videodensitometry (dissections, complex lumen) with either clinical or research purposes. In addition, the development of the gradient field transform, including a shortest path algorithm rather than the traditional smoothing algorithm, renders eccentric and complex lesions more amenable to reliable edge-detection quantitative coronary angiography analysis. Further studies, ideally using 3-D reconstruction of ECG-gated intravascular ultrasound images -obtained from motorized pullback -and, if possible, with the simultaneous use of the new players in the field (pressure-wire) [11, 12] are warranted to provide more comprehensive and definitive insights into the relative merits of each quantitative coronary angiography technique. 
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Over the last two decades, during the evolution of coronary angioplasty, it has become apparent that the development of catheters and other devices has markedly influenced the incidence of vascular complications at the arterial access site, e.g. bleedings with or without haematoma and need for transfusions, pseudoaneurysms, arterio-venous fistula and dissection. In the early days guiding catheters were large and bulky and were usually inserted without protection of an introducing sheath, which increased the risk of damage to the artery. Miniaturization of devices took place to some extent during the 1980s; however the introduction of stents and directional coronary atherectomy catheters again prompted the need for larger catheters. It also became obvious that these new treatment modalities required a more intense anticoagulation regimen, which further tended to increase bleeding risk. This was clearly demonstrated in the Benestent I trial, where a higher risk of vascular complications at the access site, necessitating surgery or blood transfusion, was noted in stented patients compared with balloon angioplasty patients [1] . A similar pattern, with a higher rate of early complications, was seen with directional coronary atherectomy [2] . Concomitant use of a bulky cardiac assist device, e.g. the intra-aortic balloon pump, was also a risk factor in this regard.
During the last decade, more potent antithrombotic drugs have been introduced in interventional cardiology. These include glycoprotein IIb/IIIa receptor blockers, in particular abciximab but also more recently integrilin and tirofiban. With the use of angioplasty in the acute myocardial infarction setting some patients will have received fibrinolytic agents before the PTCA treatment. To a lesser but probably growing extent direct thrombin inhibitors such as hirudin and hirulog, and the newer low molecular weight heparins, principally enoxaparin and dalteparin, are also being used during the procedure. In the EPIC study, the first large trial with abciximab in coronary intervention, a full dose heparin bolus was given to achieve an activated clotting time of 300-350 s. This resulted in a much higher bleeding rate with abciximab compared to placebo; 14·0% vs 6·6% [3] . A similar high incidence of bleeding was found in RAPPORT [4] , a study with abciximab in acute myocardial infarction, where the same heparin dose was employed.
Thus, although there have been several factors increasing the tendency towards more bleedings and peripheral vascular complications over the years, there have simultaneously been developments in other directions. On the pharmacological side, we have learnt to optimize the antithrombotic regimen in various ways. The use of the activated clotting time to monitor the dose and effect of heparin during the procedure has been useful in order to avoid excessive levels of anticoagulation with the associated risk of bleeding and also to ensure that a sufficient heparin dose is given to protect from thrombotic complications [5] . Use of heparin coated stents also facilitated a less aggressive anticoagulation regimen which reduced the incidence of bleedings without the occurrence of subacute stent thrombosis [6] . Another important advance was the demonstration that ticlopidine administration following stent implantation in comparison to conventional anticoagulation therapy with intravenous heparin followed by oral antivitamin K resulted in a reduced incidence of both cardiac events and haemorrhagic and vascular complications [7] . These findings have later been corroborated by other studies [8, 9] . Because of the haematological complications associated with Editorials 607
